What is the primary purpose of this debt offering?

The primary purpose of this $6.25 billion debt offering is to refinance existing debt. Specifically, HCA intends to use the proceeds to redeem all of its outstanding $1.250 billion aggregate principal amount of 4.75% senior secured notes due 2023. Additionally, proceeds may be used for general corporate purposes, which could include repaying other outstanding borrowings and potentially redeeming its 5.875% senior notes due 2023.

What are the key terms of the notes being issued?

HCA is issuing five tranches of senior secured notes: $1 billion of 3 1/8% notes due 2027, $500 million of 3 3/8% notes due 2029, $2 billion of 3 5/8% notes due 2032, $500 million of 4 3/8% notes due 2042, and $2 billion of 4 5/8% notes due 2052. These notes are guaranteed on a senior unsecured basis by the Parent Guarantor (HCA Healthcare, Inc.) and on a senior secured basis by certain subsidiary guarantors.

Are these notes being offered to the public?

No, these notes are being offered as part of a private placement. They have not been, and will not be, registered under the U.S. Securities Act of 1933 or the securities laws of any other jurisdiction. Therefore, they cannot be offered or sold in the United States to, or for the benefit of, U.S. persons, unless they are registered or an applicable exemption from registration requirements is met.

When is the offering expected to close, and what are the conditions?

The offering of these notes is expected to be completed on March 9, 2022. The closing is subject to customary closing conditions, which are standard in such financial transactions.

HCA 8-K: Material Agreements

Summary

HCA Healthcare, Inc. (HCA) announced the pricing of a significant debt offering totaling $6.25 billion across various senior secured notes with maturities ranging from 2027 to 2052. This strategic move aims to refinance existing debt, specifically intending to redeem all outstanding 4.75% senior secured notes due 2023. Additionally, proceeds may be used for general corporate purposes, potentially including the repayment of other borrowings and the redemption of 5.875% senior notes due 2023. The offering consists of notes with coupon rates ranging from 3.125% to 4.625%, reflecting a mix of short-term and long-term debt issuance. The transaction, which is expected to close on March 9, 2022, subject to customary conditions, demonstrates HCA's proactive approach to managing its capital structure and optimizing its debt profile. Investors should note that these notes are being offered privately and are not registered under the Securities Act, meaning they are not available to U.S. persons without an applicable exemption.

Key Highlights

1HCA Healthcare priced a $6.25 billion offering of senior secured notes due 2027, 2029, 2032, 2042, and 2052.
2The offering includes notes with interest rates ranging from 3 1/8% to 4 5/8%.
3Proceeds are intended for the redemption of all $1.250 billion of 4.75% senior secured notes due 2023.
4Funds may also be used for general corporate purposes, including repayment of other borrowings and redemption of 5.875% senior notes due 2023.
5The offering is expected to close on March 9, 2022, subject to customary closing conditions.
6The notes are being offered as part of a private placement and are not registered under the Securities Act.
7The transaction involves customary representations, warranties, and indemnification agreements with the initial purchasers.

HCA Healthcare, Inc. 8-K Report, Material Agreement (Mar 3, 2022)

Summary

Key Highlights

Frequently Asked Questions